Cabot (NYSE:CBT) Updates FY25 Earnings Guidance

Cabot (NYSE:CBT) updated its FY25 earnings guidance on Monday. The company provided earnings per share (EPS) guidance of $7.40-7.80 for the period, compared to the consensus estimate of $7.85. Cabot also updated its FY 2025 guidance to 7.400-7.800 EPS.

Cabot Stock Down 0.1 %

Shares of NYSE:CBT traded down $0.15 during midday trading on Thursday, reaching $116.85. The company’s stock had a trading volume of 289,331 shares, compared to its average volume of 339,714. Cabot has a 12-month low of $70.62 and a 12-month high of $117.46. The company has a quick ratio of 1.45, a current ratio of 2.22 and a debt-to-equity ratio of 0.72. The firm has a 50 day moving average of $108.69 and a 200-day moving average of $101.24. The firm has a market capitalization of $6.41 billion, a P/E ratio of 17.36, a PEG ratio of 0.92 and a beta of 1.20.

Cabot (NYSE:CBT) last announced its quarterly earnings results on Monday, November 4th. The specialty chemicals company reported $1.80 earnings per share for the quarter, missing the consensus estimate of $1.81 by ($0.01). Cabot had a net margin of 9.51% and a return on equity of 27.14%. The firm had revenue of $1 billion for the quarter, compared to the consensus estimate of $1.01 billion. During the same period last year, the business earned $1.65 EPS. Cabot’s revenue was up 3.7% on a year-over-year basis. On average, research analysts anticipate that Cabot will post 7.82 earnings per share for the current year.

Analyst Ratings Changes

Several equities research analysts have recently issued reports on CBT shares. JPMorgan Chase & Co. lifted their target price on Cabot from $95.00 to $105.00 and gave the stock a “neutral” rating in a report on Wednesday, August 7th. Mizuho lifted their price objective on shares of Cabot from $103.00 to $122.00 and gave the stock an “outperform” rating in a research note on Tuesday. Finally, UBS Group dropped their price target on Cabot from $103.00 to $98.00 and set a “neutral” rating for the company in a research report on Tuesday, August 6th. Three investment analysts have rated the stock with a hold rating and two have issued a buy rating to the company. According to data from MarketBeat, the company presently has a consensus rating of “Hold” and a consensus price target of $105.00.

Insider Buying and Selling at Cabot

In other news, EVP Hobart Kalkstein sold 5,457 shares of the business’s stock in a transaction on Tuesday, August 20th. The shares were sold at an average price of $100.58, for a total transaction of $548,865.06. Following the completion of the sale, the executive vice president now directly owns 61,688 shares of the company’s stock, valued at approximately $6,204,579.04. The trade was a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. In other Cabot news, CFO Erica Mclaughlin sold 16,390 shares of Cabot stock in a transaction dated Tuesday, August 27th. The stock was sold at an average price of $104.24, for a total value of $1,708,493.60. Following the transaction, the chief financial officer now owns 59,814 shares in the company, valued at $6,235,011.36. The trade was a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Also, EVP Hobart Kalkstein sold 5,457 shares of the stock in a transaction dated Tuesday, August 20th. The shares were sold at an average price of $100.58, for a total transaction of $548,865.06. Following the sale, the executive vice president now directly owns 61,688 shares of the company’s stock, valued at approximately $6,204,579.04. The trade was a 0.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold 48,665 shares of company stock worth $4,986,299 over the last 90 days. Company insiders own 3.07% of the company’s stock.

About Cabot

Cabot Corporation operates as a specialty chemicals and performance materials company. The company operates through two segments, Reinforcement Materials and Performance Chemicals. It offers reinforcing carbons that are used in tires as a rubber reinforcing agent and performance additive, as well as in industrial products, such as hoses, belts, extruded profiles, and molded goods; and engineered elastomer composites solutions.